Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorLESCOAT, Alain
dc.contributor.authorBELLANDO-RANDONE, Silvia
dc.contributor.authorCAMPOCHIARO, Corrado
dc.contributor.authorDEL GALDO, Francesco
dc.contributor.authorDENTON, Christopher P
dc.contributor.authorFARRINGTON, Sue
dc.contributor.authorGALETTI, Ilaria
dc.contributor.authorKHANNA, Dinesh
dc.contributor.authorKUWANA, Masataka
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorTRUCHETET, Marie-Elise
dc.contributor.authorALLANORE, Yannick
dc.contributor.authorMATUCCI-CERINIC, Marco
dc.date.accessioned2024-09-17T12:10:43Z
dc.date.available2024-09-17T12:10:43Z
dc.date.issued2023
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201625
dc.description.abstractEnThe identification of individuals with systemic sclerosis in an oligosymptomatic phase preceding the very early manifestations of the disease represents a challenge in the search for a new window of opportunity in systemic sclerosis. This phase could be identified in a clinical scenario as the pre-scleroderma phase, in which the disease would still be far from systemic sclerosis-related fibrotic or irreversible manifestations in skin or organs. In this Personal View, we discuss parameters and candidate definitions for a conceptual framework of pre-scleroderma, from the identification of populations at risk to autoantibodies and their potential functional activities. We discuss how this new paradigm of pre-scleroderma could represent a game-changing approach in the management of systemic sclerosis, allowing the treatment of patients at high risk of organ involvement or skin fibrosis before such events occur
dc.language.isoENen_US
dc.title.enBeyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/S2665-9913(23)00212-6en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed38251534en_US
bordeaux.journalThe Lancet Rheumatologyen_US
bordeaux.pagee683-e694en_US
bordeaux.volume5en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue11en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=The%20Lancet%20Rheumatology&rft.date=2023&rft.volume=5&rft.issue=11&rft.spage=e683-e694&rft.epage=e683-e694&rft.au=LESCOAT,%20Alain&BELLANDO-RANDONE,%20Silvia&CAMPOCHIARO,%20Corrado&DEL%20GALDO,%20Francesco&DENTON,%20Christopher%20P&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée